enhancing the efficacy of immune checkpoint inhibitors in crc
Published 1 year ago • 69 plays • Length 0:55Download video MP4
Download video MP3
Similar videos
-
0:24
how can we incorporate checkpoint inhibition in microsatellite stable colorectal cancer?
-
1:05
limitations in immune checkpoint inhibitors in treating gastric cancer
-
1:19
modulating the gut microbiome to improve immune checkpoint inhibitor efficacy
-
1:01
improving the efficacy of immunotherapy using anti-angiogenic agents in gi malignancies
-
5:30
expert report on immune checkpoint inhibitors for dmmr colorectal cancer
-
38:07
biocompatibility - ch. 18 - immunity to tumors
-
37:26
cancer immunotherapy basics: understand the science behind this cutting-edge treatment
-
31:04
what's new for colorectal cancer treatment?
-
3:44
investigating ezabenlimab in combination with a vegf/ang2-blocking nanobody for advanced crc
-
2:24
the remaining challenges surrounding the use of immunotherapy to treat patients with rectal cancer
-
2:47
immunotherapy plus tkis for the treatment of crc
-
1:14
how can we continue the success of checkpoint inhibitors for bladder cancer treatment?
-
0:51
addressing resistance to icis in colorectal cancer
-
0:49
novel immunotherapy approaches for mmr-proficient colorectal cancer
-
1:18
botensilimab and balstilimab in metastatic, pre-treated mss-crc
-
20:02
optimizing strategies for the treatment of colorectal cancer in the biomarker era
-
2:55
analysis of hla gene expression in dmmr/msi-h, ici-resistant crc
-
1:10
predicting survival outcomes in colorectal cancer with the sting pathway
-
0:41
how can immunotherapies successfully target mss colorectal cancer?
-
1:14
current and future trends in immunotherapy for msi-h colorectal cancer
-
4:36
immune-related adverse events and efficacy of checkpoint inhibitors in gastrointestinal cancer